BANGALORE, India--(BUSINESS WIRE)--Kemwell Biopharma Pvt. Ltd., a global bio/pharmaceutical contract development and manufacturing company, announced today that its oral solids manufacturing facility located in Bangalore, India has successfully completed its ANIVSA inspection by the Brazilian regulatory body. Kemwell has been regularly shipping products to Europe, Australia, Canada and USA from this facility.
On completion of the inspection, the ANVISA inspector concluded that the facility systems and practices comply with ANVISA requirements and the audit was completed with no open points.
Help employers find you! Check out all the jobs and post your resume.
On completion of the inspection, the ANVISA inspector concluded that the facility systems and practices comply with ANVISA requirements and the audit was completed with no open points.
Help employers find you! Check out all the jobs and post your resume.
